HBV-associated cryoglobulinemic vasculitis: Remission after antiviral therapy with entecavir

Mauro Viganò, Paul Martin, Mattia Cappelletti, Fabrizio Fabrizi

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background/Aims: Cryoglobulinemic vasculitis remains an uncommon complication of hepatitis B virus infection. Methods: We report the case of a 40-years old female Chinese patient with chronic hepatitis B developing cryoglobulinemic vasculitis with multiple organ involvement (liver, kidney, and skin) coupled with weakness, arthralgias, haemolytic anaemia, and autoimmune thyroiditis. She received entecavir mono-therapy at dose adjusted for estimated glomerular filtration rate. Results: Within five months of entecavir treatment, hepatitis B viraemia decreased below the limit of detection with normal serum amino-transferase levels, HBeAg clearance occurred, vasculitis regressed with disappearance of purpura and ascites; in addition, renal function normalized and nephritic syndrome remitted. After a five-year follow-up, the patient is asymptomatic with intact kidney function, proteinuria in the normal range, and normal liver biochemistry, despite the antiviral treatment was withdrawn and the patient remained HBsAg positive. Conclusions: This is the second case of hepatitis B virus-related cryoglobulinemic vasculitis successfully treated with entecavir suggesting that effective antiviral therapy may counteract both the hepatic and extra-hepatic manifestations of infection by hepatitis B virus.

Original languageEnglish
Pages (from-to)65-73
Number of pages9
JournalKidney and Blood Pressure Research
Volume39
Issue number1
DOIs
StatePublished - Jan 1 2014

Fingerprint

Vasculitis
Antiviral Agents
Hepatitis B virus
Kidney
Liver
Autoimmune Thyroiditis
Purpura
Hepatitis B e Antigens
Viremia
Hemolytic Anemia
Chronic Hepatitis B
Arthralgia
Virus Diseases
Therapeutics
Hepatitis B Surface Antigens
Transferases
Hepatitis B
Glomerular Filtration Rate
Proteinuria
Ascites

Keywords

  • Antiviral therapy
  • Cryoglobulinemia
  • Entecavir
  • Hepatitis B virus
  • Vasculitis

ASJC Scopus subject areas

  • Nephrology
  • Cardiology and Cardiovascular Medicine

Cite this

HBV-associated cryoglobulinemic vasculitis : Remission after antiviral therapy with entecavir. / Viganò, Mauro; Martin, Paul; Cappelletti, Mattia; Fabrizi, Fabrizio.

In: Kidney and Blood Pressure Research, Vol. 39, No. 1, 01.01.2014, p. 65-73.

Research output: Contribution to journalArticle

Viganò, Mauro ; Martin, Paul ; Cappelletti, Mattia ; Fabrizi, Fabrizio. / HBV-associated cryoglobulinemic vasculitis : Remission after antiviral therapy with entecavir. In: Kidney and Blood Pressure Research. 2014 ; Vol. 39, No. 1. pp. 65-73.
@article{4524d50d1b2840ae9128b7a2e945e48f,
title = "HBV-associated cryoglobulinemic vasculitis: Remission after antiviral therapy with entecavir",
abstract = "Background/Aims: Cryoglobulinemic vasculitis remains an uncommon complication of hepatitis B virus infection. Methods: We report the case of a 40-years old female Chinese patient with chronic hepatitis B developing cryoglobulinemic vasculitis with multiple organ involvement (liver, kidney, and skin) coupled with weakness, arthralgias, haemolytic anaemia, and autoimmune thyroiditis. She received entecavir mono-therapy at dose adjusted for estimated glomerular filtration rate. Results: Within five months of entecavir treatment, hepatitis B viraemia decreased below the limit of detection with normal serum amino-transferase levels, HBeAg clearance occurred, vasculitis regressed with disappearance of purpura and ascites; in addition, renal function normalized and nephritic syndrome remitted. After a five-year follow-up, the patient is asymptomatic with intact kidney function, proteinuria in the normal range, and normal liver biochemistry, despite the antiviral treatment was withdrawn and the patient remained HBsAg positive. Conclusions: This is the second case of hepatitis B virus-related cryoglobulinemic vasculitis successfully treated with entecavir suggesting that effective antiviral therapy may counteract both the hepatic and extra-hepatic manifestations of infection by hepatitis B virus.",
keywords = "Antiviral therapy, Cryoglobulinemia, Entecavir, Hepatitis B virus, Vasculitis",
author = "Mauro Vigan{\`o} and Paul Martin and Mattia Cappelletti and Fabrizio Fabrizi",
year = "2014",
month = "1",
day = "1",
doi = "10.1159/000355778",
language = "English",
volume = "39",
pages = "65--73",
journal = "Kidney and Blood Pressure Research",
issn = "1420-4096",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - HBV-associated cryoglobulinemic vasculitis

T2 - Remission after antiviral therapy with entecavir

AU - Viganò, Mauro

AU - Martin, Paul

AU - Cappelletti, Mattia

AU - Fabrizi, Fabrizio

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Background/Aims: Cryoglobulinemic vasculitis remains an uncommon complication of hepatitis B virus infection. Methods: We report the case of a 40-years old female Chinese patient with chronic hepatitis B developing cryoglobulinemic vasculitis with multiple organ involvement (liver, kidney, and skin) coupled with weakness, arthralgias, haemolytic anaemia, and autoimmune thyroiditis. She received entecavir mono-therapy at dose adjusted for estimated glomerular filtration rate. Results: Within five months of entecavir treatment, hepatitis B viraemia decreased below the limit of detection with normal serum amino-transferase levels, HBeAg clearance occurred, vasculitis regressed with disappearance of purpura and ascites; in addition, renal function normalized and nephritic syndrome remitted. After a five-year follow-up, the patient is asymptomatic with intact kidney function, proteinuria in the normal range, and normal liver biochemistry, despite the antiviral treatment was withdrawn and the patient remained HBsAg positive. Conclusions: This is the second case of hepatitis B virus-related cryoglobulinemic vasculitis successfully treated with entecavir suggesting that effective antiviral therapy may counteract both the hepatic and extra-hepatic manifestations of infection by hepatitis B virus.

AB - Background/Aims: Cryoglobulinemic vasculitis remains an uncommon complication of hepatitis B virus infection. Methods: We report the case of a 40-years old female Chinese patient with chronic hepatitis B developing cryoglobulinemic vasculitis with multiple organ involvement (liver, kidney, and skin) coupled with weakness, arthralgias, haemolytic anaemia, and autoimmune thyroiditis. She received entecavir mono-therapy at dose adjusted for estimated glomerular filtration rate. Results: Within five months of entecavir treatment, hepatitis B viraemia decreased below the limit of detection with normal serum amino-transferase levels, HBeAg clearance occurred, vasculitis regressed with disappearance of purpura and ascites; in addition, renal function normalized and nephritic syndrome remitted. After a five-year follow-up, the patient is asymptomatic with intact kidney function, proteinuria in the normal range, and normal liver biochemistry, despite the antiviral treatment was withdrawn and the patient remained HBsAg positive. Conclusions: This is the second case of hepatitis B virus-related cryoglobulinemic vasculitis successfully treated with entecavir suggesting that effective antiviral therapy may counteract both the hepatic and extra-hepatic manifestations of infection by hepatitis B virus.

KW - Antiviral therapy

KW - Cryoglobulinemia

KW - Entecavir

KW - Hepatitis B virus

KW - Vasculitis

UR - http://www.scopus.com/inward/record.url?scp=84903859753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903859753&partnerID=8YFLogxK

U2 - 10.1159/000355778

DO - 10.1159/000355778

M3 - Article

C2 - 25011658

AN - SCOPUS:84903859753

VL - 39

SP - 65

EP - 73

JO - Kidney and Blood Pressure Research

JF - Kidney and Blood Pressure Research

SN - 1420-4096

IS - 1

ER -